Previous studies have provided inconsistent results about the cardiovascular risks for participants with metabolically healthy obesity (MHO). These uncertainties might partly reflect the lack of a uniform definition of MHO. We conducted a systematic review and meta-analysis to examine whether there is a suitable approach that identifies obese participants who are not at an increased risk of cardiovascular events compared with healthy normal-weight participants.
Methods and results
Twenty-two prospective studies were eligible for the meta-analysis. Using random-effect models, pooled relative risks (RRs) were calculated for the combined effects of obesity with the presence or absence of metabolic syndrome, insulin resistance, hypertension, diabetes, hyperlipidaemia and any of these metabolic factors. Participants with MHO defined by the absence of metabolic syndrome were at increased risk for cardiovascular events compared with healthy normal-weight participants (pooled RR 1.45, 95% confidence interval (CI) 1.20–1.70), but had lower risks than unhealthy normal-weight (RR 2.07, 95% CI 1.62–2.65) and obese (RR 2.31, 95% CI 1.99–2.69) participants. The risk associated with participants who had MHO was particularly high over the long term. Similar risk estimates were observed when MHO was defined by other approaches.
Conclusions
None of the approaches clearly identified an obese subgroup not at increased risk of cardiovascular events compared with normal-weight healthy participants. A benign obese phenotype might be defined by strict definitions, but insufficient studies exist to support this. More research is needed to better define MHO.
NgMFlemingTRobinsonM. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet2014; 384: 766–781.
4.
Van GaalLFMertensILDe BlockCE. Mechanisms linking obesity with cardiovascular disease. Nature2006; 444: 875–880.
5.
WhitlockGLewingtonSSherlikerP. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet2009; 373: 1083–1096.
6.
DudinaACooneyMTBacquerDD. Relationships between body mass index, cardiovascular mortality, and risk factors: a report from the SCORE investigators. Eur J Cardiovasc Prev Rehabil2011; 18: 731–742.
7.
WildmanRPMuntnerPReynoldsK. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med2008; 168: 1617–1624.
8.
StefanNKantartzisKMachannJ. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med2008; 168: 1609–1616.
9.
Rey-LopezJPde RezendeLFPastor-ValeroM. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes Rev2014; 15: 781–790.
KramerCKZinmanBRetnakaranR. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med2013; 159: 758–769.
12.
LawlorDAHartCLHoleDJ. Reverse causality and confounding and the associations of overweight and obesity with mortality. Obesity (Silver Spring)2006; 14: 2294–2304.
13.
StroupDFBerlinJAMortonSC. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA2000; 283: 2008–2012.
14.
Wells G, Shea B, O'Connell D, et al. The Newcastle–Ottowa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Department of Epidemiology and Community Medicine, University of Ottawa, Canada, www.ohri.ca/programs/clinical_epidemiology/oxford.htm (2011, accessed 22 January 2015).
15.
ThomsenMNordestgaardBG. Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic syndrome. JAMA Intern Med2014; 174: 15–22.
16.
BoSMussoGGambinoR. Prognostic implications for insulin-sensitive and insulin-resistant normal-weight and obese individuals from a population-based cohort. Am J Clin Nutr2012; 96: 962–969.
17.
MorkedalBVattenLJRomundstadPR. Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trondelag Health Study), Norway. J Am Coll Cardiol2014; 63: 1071–1078.
18.
KatzmarzykPTChurchTSJanssenI. Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care2005; 28: 391–397.
19.
HigginsJPThompsonSGDeeksJJ. Measuring inconsistency in meta-analyses. BMJ2003; 327: 557–560.
20.
SterneJAEggerMSmithGD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ2001; 323: 101–105.
21.
HinnouhoGMCzernichowSDugravotA. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?Diabetes Care2013; 36: 2294–2300.
22.
HinnouhoGMCzernichowSDugravotA. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J2015; 36: 551–559.
23.
VoulgariCTentolourisNDilaverisP. Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals. J Am Coll Cardiol2011; 58: 1343–1350.
24.
MorkedalBRomundstadPRVattenLJ. Mortality from ischaemic heart disease: age-specific effects of blood pressure stratified by body-mass index: the HUNT cohort study in Norway. J Epidemiol Community Health2011; 65: 814–819.
25.
ArnlovJIngelssonESundstromJ. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation2010; 121: 230–236.
26.
JensenMKChiuveSERimmEB. Obesity, behavioral lifestyle factors, and risk of acute coronary events. Circulation2008; 117: 3062–3069.
27.
JonssonSHedbladBEngstromG. Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population. Int J Obes Relat Metab Disord2002; 26: 1046–1053.
28.
MahamatARichardFArveilerD. Body mass index, hypertension and 5-year coronary heart disease incidence in middle aged men: the PRIME study. J Hypertens2003; 21: 519–524.
29.
AungKLorenzoCHinojosaMA. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab2014; 99: 462–468.
30.
SongYMansonJEMeigsJB. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol2007; 100: 1654–1658.
31.
MeigsJBWilsonPWFoxCS. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab2006; 91: 2906–2912.
32.
WeiMKampertJBBarlowCE. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA1999; 282: 1547–1553.
MannDMLeeJLiaoY. Independent effect and population impact of obesity on fatal coronary heart disease in adults. Prev Med2006; 42: 66–72.
35.
AppletonSLSeabornCJVisvanathanR. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care2013; 36: 2388–2394.
36.
St-PierreACCantinBMauriegeP. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ2005; 172: 1301–1305.
37.
HosseinpanahFBarzinMSheikholeslamiF. Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS). Am J Cardiol2011; 107: 412–416.
38.
SaitoIIsoHKokuboY. Body mass index, weight change and risk of stroke and stroke subtypes: the Japan Public Health Center-based prospective (JPHC) study. Int J Obes (Lond)2011; 35: 283–291.
39.
KurthTGazianoJMBergerK. Body mass index and the risk of stroke in men. Arch Intern Med2002; 162: 2557–2562.
40.
RexrodeKMHennekensCHWillettWC. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA1997; 277: 1539–1545.
41.
MansonJEColditzGAStampferMJ. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med1990; 322: 882–889.
42.
FlintAJRexrodeKMHuFB. Body mass index, waist circumference, and risk of coronary heart disease: a prospective study among men and women. Obes Res Clin Pract2010; 4: e171–e181.
43.
ZhangCRexrodeKMvan DamRM. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation2008; 117: 1658–1667.
44.
LiCEngstromGHedbladB. Sex differences in the relationships between BMI, WHR and incidence of cardiovascular disease: a population-based cohort study. Int J Obes (Lond)2006; 30: 1775–1781.
45.
FolsomARKushiLHAndersonKE. Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. Arch Intern Med2000; 160: 2117–2128.
46.
LeeCDJacksonASBlairSN. US weight guidelines: is it also important to consider cardiorespiratory fitness?Int J Obes Relat Metab Disord1998; 22(Suppl 2): S2–S7.
47.
FarrellSWFinleyCERadfordNB. Cardiorespiratory fitness, body mass index, and heart failure mortality in men: Cooper Center Longitudinal Study. Circ Heart Fail2013; 6: 898–905.
48.
FanJSongYChenY. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol2013; 168: 4761–4768.
49.
RobersonLLAneniECMaziakW. Beyond BMI: the “metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality – a systematic review. BMC Public Health2014; 14: 14–14.
50.
VelhoSPaccaudFWaeberG. Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr2010; 64: 1043–1051.
51.
RidkerPMWilsonPWGrundySM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?Circulation2004; 109: 2818–2825.
52.
SantaniemiMUkkolaOMaloE. Metabolic syndrome in the prediction of cardiovascular events: the potential additive role of hsCRP and adiponectin. Eur J Prev Cardiol2014; 21: 1242–1248.
53.
AlamINgTPLarbiA. Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective. Mediators Inflamm2012; 2012: 456–456.
54.
StienstraRStefanN. Tipping the inflammatory balance: inflammasome activation distinguishes metabolically unhealthy from healthy obesity. Diabetologia2013; 56: 2343–2346.
55.
Aguilar-SalinasCAGarciaEGRoblesL. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab2008; 93: 4075–4079.
56.
MessierVKarelisADRobillardME. Metabolically healthy but obese individuals: relationship with hepatic enzymes. Metabolism2010; 59: 20–24.
57.
BogersRPBemelmansWJHoogenveenRT. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med2007; 167: 1720–1728.
58.
LuYHajifathalianKEzzatiM. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet2014; 383: 970–983.
59.
SoriguerFGutierrez-RepisoCRubio-MartinE. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab2013; 98: 2318–2325.
60.
Bobbioni-HarschEPatakyZMakoundouV. From metabolic normality to cardiometabolic risk factors in subjects with obesity. Obesity (Silver Spring)2012; 20: 2063–2069.
61.
MullerMJLagerpuschMEnderleJ. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev2012; 13(Suppl 2): 6–13.
62.
CarmienkeSFreitagMHPischonT. General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and meta-regression analysis. Eur J Clin Nutr2013; 67: 573–585.
63.
WormserDKaptogeSDi AngelantonioE. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet2011; 377: 1085–1095.
64.
BarryVWBaruthMBeetsMW. Fitness vs. fatness on all-cause mortality: a meta-analysis. Prog Cardiovasc Dis2014; 56: 382–390.
65.
Connor GorberSTremblayMMoherD. A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review. Obes Rev2007; 8: 307–326.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
